Paclitaxel derivatives for the treatment of cancer
US6395771B1 · kind B1 · utility
10Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2000 |
| Grant date | May 28, 2002 |
| Priority date | — |
| Expiry date | May 31, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides novel paclitaxel derivatives obtained by effecting modifications at C2′, C3′ and/or C7 positions of paclitaxel, said derivatives being useful in inhibiting the growth of cancer of lung, breast, ovary, cervix or leukemia, and pharmaceutical compositions comprising such derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.